Pharma Focus Asia

GeneFab Constructs New Manufacturing Facility in California, USA

Introduction:

GeneFab plans to construct a state-of-the-art cGMP facility in California, USA, dedicated to the diverse spectrum of genetic medicines.

Features:

This state-of-the-art facility will provide groundbreaking services in the realms of manufacturing and synthetic biology design, catering to a wide spectrum of genetic medicine needs.

The forthcoming cGMP facility, spans an impressive 92,000 square feet. Within this cutting-edge establishment, a substantial 42,000 square feet is exclusively reserved for the production of pioneering Phase 1/2 clinical trial materials.

This cutting-edge facility is well-equipped to support complex cell and gene therapy manufacturing. This includes meeting the needs for different types of cell therapy (allogeneic and autologous), producing viral vectors, and providing essential cell banking services.

The use of advanced capabilities and skills transforms the scientific innovation into tangible treatments, and provides life-changing therapies to patients in need. 

Specifications:

Name  GeneFab
Type  New Construction

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?